JP

Jharna Palia

Active Director Director DIN 08573771
DIN 08573771 First appointment Sep 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Jharna Palia

Data last updated:

Jharna Palia is a Director at Synovion Laboratories Private Limited (since 2019). The company operates in Pharma. Synovion Laboratories Private Limited reported revenue of ₹3.01 Cr (FY 2024).

DIN 08573771
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2019
Oldest Company Age 13 yrs
Largest company Synovion Laboratories Private Limited · ₹3.01 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20192013₹3.01 Cr (FY 2024)Active

Board colleagues of Jharna Palia

NameDINCompanyDesignation
Gaurav Palia06553885Synovion Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Synovion Laboratories Private Limited
Premium access

Shareholding and investment profile for Jharna Palia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jharna Palia

Jharna Palia currently holds 1 directorship: Synovion Laboratories Private Limited (Director, since 30 Sep 2019, revenue ₹3.01 Cr (FY 2024)).

Jharna Palia was first appointed on 30 Sep 2019 as Director at Synovion Laboratories Private Limited.

The current boards of Jharna Palia's companies include Gaurav Palia (Synovion Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available